Section Arrow
CV.NASDAQ
- CapsoVision
Quotes are at least 15-min delayed:2025/10/23 16:29 EDT
After Hours
Last
 4.91
0 (0.00%)
Bid
4.5
Ask
5
High 4.91 
Low 4.91 
Volume 611 
Regular Hours
Last
 4.91
-0.03 (-0.61%)
Day High 
4.96 
Prev. Close
4.94 
1-M High
4.99 
Volume 
17.55K 
Bid
4.5
Ask
5
Day Low
4.77 
Open
4.88 
1-M Low
4.34 
Market Cap 
231.06M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 4.72 
20-SMA 4.7 
50-SMA 4.3 
52-W High 5.72 
52-W Low 3.4341 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.44/-0.22
Enterprise Value
231.95M
Balance Sheet
Book Value Per Share
-2.97
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
11.76M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITGRInteger Holdings Corp73.89-35.22-32.28%46.63PE
After Hours 73.48 -0.41 -0.55%
QSIQuantum-Si2.2--0.000%-- 
After Hours 2.21 +0.01 +0.45%
BSXBoston Scientific Corp102.39-1.46-1.41%62.08PE
After Hours 102.39 0 0.00%
PACBPacific Biosciences of California1.95+0.11+5.98%-- 
After Hours 1.94 -0.01 -0.51%
MDTMedtronic plc94.21-1.69-1.76%26.49PE
After Hours 94.21 0 0.00%
Quotes are at least 15-min delayed:2025/10/23 16:29 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.